Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Everest Medicines Announces Official Acceptance Granted on NEFECON® Supplementary Application by China National Medical Products Administration 2024-07-18 08:00
Increasing Possibility of Success by Expanded Antibody Repertoires with Lambda Light Chain - Immunocan Launches New Mouse Strain of Fully Human Antibody Platform: ImmuMab® HKL Mouse 2024-07-17 21:50
First procedure in Netherlands with NaoTrac surgical navigation robot is performed at Erasmus MC Rotterdam 2024-07-17 15:49
111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024 2024-07-17 13:31
GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities 2024-07-17 10:38
CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe 2024-07-17 10:16
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks 2024-07-16 23:55
FDA Grants Orphan Drug Designation to 7MW3711 2024-07-16 22:00
Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024 2024-07-16 21:00
SPI Pharma, Inc. and Inimmune, Corp. Partner to Develop and Commercialize Innovative Vaccine Adjuvant Systems 2024-07-16 21:00
Sanyou Bio Collaborates on ADC Drug Development Entering Phase I Clinical Trials 2024-07-16 20:00
Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma 2024-07-16 17:10
Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC 2024-07-15 22:00
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer 2024-07-15 19:00
CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area 2024-07-15 13:59
Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2024-07-15 13:44
Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1 2024-07-15 12:17
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases 2024-07-12 16:53
First Patient Dosed in Phase I Clinical Trial of YOLT-201 2024-07-11 20:11
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-07-11 20:00
1 32 33 34 35 36 421